The administration of concanavalin A (Con A) induces a rapid severe injury of hepatocytes in mice. Although the Con A–induced hepatitis is considered to be an experimental model of human autoimmune hepatitis, the precise cellular and molecular mechanisms that induce hepatocyte injury remain unclear. Here, we demonstrate that Vα14 NKT cells are required and sufficient for induction of this hepatitis. Moreover, interleukin (IL)-4 produced by Con A–activated Vα14 NKT cells is found to play a crucial role in disease development by augmenting the cytotoxic activity of Vα14 NKT cells in an autocrine fashion. Indeed, short-term treatment with IL-4 induces an increase in the expression of granzyme B and Fas ligand (L) in Vα14 NKT cells. Moreover, Vα14 NKT cells from either perforin knock-out mice or FasL-mutant gld/gld mice fail to induce hepatitis, and hence perforin–granzyme B and FasL appear to be effector molecules in Con A–induced Vα14 NKT cell–mediated hepatocyte injury.
Skip Nav Destination
Article navigation
3 January 2000
Article|
January 03 2000
Augmentation of Vα14 Nkt Cell–Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a–Induced Hepatitis
Yoshikatsu Kaneko,
Yoshikatsu Kaneko
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Michishige Harada,
Michishige Harada
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Tetsu Kawano,
Tetsu Kawano
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Masakatsu Yamashita,
Masakatsu Yamashita
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Youichi Shibata,
Youichi Shibata
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Fumitake Gejyo,
Fumitake Gejyo
bDepartment of Internal Medicine, School of Medicine, Niigata University, Niigata 951-8510, Japan
Search for other works by this author on:
Toshinori Nakayama,
Toshinori Nakayama
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Masaru Taniguchi
Masaru Taniguchi
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Yoshikatsu Kaneko
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Michishige Harada
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Tetsu Kawano
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Masakatsu Yamashita
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Youichi Shibata
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Fumitake Gejyo
bDepartment of Internal Medicine, School of Medicine, Niigata University, Niigata 951-8510, Japan
Toshinori Nakayama
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Masaru Taniguchi
aFrom CREST (Core Research for Evolutional Science and Technology) and the Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Received:
August 20 1999
Revision Requested:
October 18 1999
Accepted:
October 28 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 191 (1): 105–114.
Article history
Received:
August 20 1999
Revision Requested:
October 18 1999
Accepted:
October 28 1999
Citation
Yoshikatsu Kaneko, Michishige Harada, Tetsu Kawano, Masakatsu Yamashita, Youichi Shibata, Fumitake Gejyo, Toshinori Nakayama, Masaru Taniguchi; Augmentation of Vα14 Nkt Cell–Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a–Induced Hepatitis. J Exp Med 3 January 2000; 191 (1): 105–114. doi: https://doi.org/10.1084/jem.191.1.105
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement